Changyong Li

11PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Nutrigenomics and personalised nutritionTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 08, 2025
Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Progression of Osteoarthritis by Suppressing NLRP3-Mediated Synovial Inflammation in the Early Stages of the Disease.

Yu Li, Yu Ouyang, Ruibo Lang

|Sep 13, 2024
Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway.

Jing He, Chunchun Ao, Mao Li

|Aug 14, 2024
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling.

Ruobin Zong, Yan Zheng, Yufei Yan

|Apr 04, 2024
Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling.

Ke Zhang, Shuo Zheng, Jiasheng Wu

|Feb 25, 2024
A highly sensitive and specific Homo1-based real-time qPCR method for quantification of human umbilical cord mesenchymal stem cells in rats.

Jing He, Zhangfan Wang, Chunchun Ao

|Feb 15, 2024
Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathway.

Ming Ni, Jiannan Qiu, Guoqing Liu

Pageof 2

Frequent Collaborators

4 joint publications

Dongcheng Wu

2 joint publications

Yu Li

1 joint publications

Lian Chen

1 joint publications

Xiaoxing Xiong